The New York Stock Exchange and other regulators are shifting the focus of their market-timing investigations from mutual fund companies and hedge funds to individual brokers and their supervisors, ...
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion that the pharmaceutical giant delayed announcing a successful Covid-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback